Susan Domchek

Professor, Clinician-Educator

University of Pennsylvania

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Science Medical Science professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Susan Domchek is a Professor and Clinician-Educator at the University of Pennsylvania in the United States. Her research focuses on cancer genetics, particularly the implications of germline mutations in BRCA1 and BRCA2, as well as the impact of digital health innovations on patient understanding of genetic testing. Recent articles authored by Dr. Domchek explore topics such as eHealth delivery alternatives for cancer genetic testing, the development of digital health portals, and the relationship between hormonal contraception and breast cancer risk.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (18)

Martha Hickey

University of Melbourne

AUSTRALIA

Susan Domchek

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Developing the MyCancerGene Digital Health Portal to Improve Patients’ Understanding of Germline Cancer Genetic Test Results: Development, User, and Usability Testing Study

Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2

An eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Patients With Metastatic Cancers: Protocol for a Randomized Trial

Prevalence of H. pylori and Gastric Intestinal Metaplasia in BRCA1 and BRCA2 Carriers

Toward Application of Polygenic Risk Scores to Both Enhance and Deintensify Breast Cancer Screening

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline

Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing.

Advancing Cancer Interception

WHAM—A Prospective Study of Weight and Body Composition After Risk-Reducing Bilateral Salpingo-oophorectomy

Care after premenopausal risk‐reducing salpingo‐oophorectomy in high‐risk women: Scoping review and international consensus recommendations

PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer

EUS-based pancreatic cancer surveillance in BRCA1/BRCA2/PALB2/ATM carriers without a family history of pancreatic cancer

Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model

Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations

Germline genetic testing for breast cancer: which patients? What genes?

Splicing profile by capture RNA-seq identifies pathogenic germline variants in tumor suppressor genes

Endoscopic Ultrasound Has Limited Utility in Diagnosis of Gastric Cancer in Carriers of CDH1 Mutations

Collaborators (18)

Martha Hickey

Graham Mann

Brian Egleston

Daniel J. Powell

Kara Maxwell

Judith Balmaña

Emma Crosbie

Lynne I. Wagner

Joanne Kotsopoulos

Usha Menon

Kim A. Reiss

S. Rozenberg

Kelly Metcalfe

Helen Hanson

Barbara Norquist

Kirk Wangensteen

Paul Cohen

Vincent Singh Paramanandam

Make your next move.